Asthma-COPD Overlap Phenotypes and Smoking :Comparative features of asthma in smoking or non-smoking patients with an incomplete reversibility of airway obstruction

References

• Lougheed MD, Lemiere C, Ducharme FM, Licskai C, Dell SD, Rowe BH, et al. Canadian Thoracic Society 2012 guideline update: diagnosis and management of asthma in preschoolers, children and adults. Can Respir J. 2012;19(2):127–64. doi:10.1155/2012/635624.
   PubMed Web of Science ®Google Scholar
• Boulet LP, Turcotte H, Turcot O, Chakir J. Airway inflammation in asthma with incomplete reversibility of airflow obstruction. Respir Med. 2003;97(6):739–44. doi:10.1053/rmed.2003.1491.
   PubMed Web of Science ®Google Scholar
• Ulrik CS, Backer V. Nonreversible airflow obstruction in life-long nonsmokers with moderate to severe asthma. Eur Respir J. 1999;14(4):892–6. doi:10.1034/j.1399-3003.1999.14d27.x.
   PubMed Web of Science ®Google Scholar
• Ten Brinke A, Zwinderman AH, Sterk PJ, Rabe KF, Bel EH. Factors associated with persistent airflow limitation in severe asthma. Am J Respir Crit Care Med. 2001;164(5):744–8. doi:10.1164/ajrccm.164.5.2011026.
   PubMed Web of Science ®Google Scholar
• Ten Brinke A. Risk factors associated with irreversible airflow limitation in asthma. Curr Opin Allergy Clin Immunol. 2008;8(1):63–9. doi:10.1097/ACI.0b013e3282f3b5b5.
   PubMed Web of Science ®Google Scholar
• Lee JH, Haselkorn T, Borish L, Rasouliyan L, Chipps BE, Wenzel SE. Risk factors associated with persistent airflow limitation in severe or difficult-to-treat asthma: insights from the TENOR study. Chest 2007;132(6):1882–9. doi:10.1378/chest.07-0713.
   PubMed Web of Science ®Google Scholar
• Zhang L, He L, Gong J, Liu C. Risk factors associated with irreversible airway obstruction in asthma: a systematic review and meta-analysis. BioMed Res Int.2016;2016:9868704.
   PubMedGoogle Scholar
• Fabbri LM, Romagnoli M, Corbetta L, Casoni G, Busljetic K, Turato G, et al. Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2003;167(3):418–24. doi:10.1164/rccm.200203-183OC.
   PubMed Web of Science ®Google Scholar
• Boulet LP, Turcotte H, Hudon C, Carrier G, Maltais F. Clinical, physiological and radiological features of asthma with incomplete reversibility of airflow obstruction compared with those of COPD. Can Respir J. 1998;5(4):270–7. doi:10.1155/1998/780739.
   PubMedGoogle Scholar
• de Marco R, Pesce G, Marcon A, Accordini S, Antonicelli L, Bugiani M, et al. The coexistence of asthma and chronic obstructive pulmonary disease (COPD): prevalence and risk factors in young, middle-aged and elderly people from the general population. PLoS One. 2013;8(5):e62985.doi:10.1371/journal.pone.0062985.
   PubMed Web of Science ®Google Scholar
• Jang AS, Lee JH, Park SW, Park JS, Kim DJ, Park CS. Risk factors related to fixed airway obstruction in patients with asthma after antiasthma treatment. Ann Allergy Asthma Immunol. 2007;99(5):408–12. doi:10.1016/S1081-1206(10)60564-9.
   PubMed Web of Science ®Google Scholar
• Polosa R, Thomson NC. Smoking and asthma: dangerous liaisons. Eur Respir J. 2013;41(3):716–26. doi:10.1183/09031936.00073312.
   PubMed Web of Science ®Google Scholar
• Lange P, Parner J, Vestbo J, Schnohr P, Jensen G. A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med. 1998;339(17):1194–200. doi:10.1056/NEJM199810223391703.
   PubMed Web of Science ®Google Scholar
• Kleis S, Chanez P, Delvaux M, Louis R. Perception of dyspnea in mild smoking asthmatics. Respir Med. 2007;101(7):1426–30. doi:10.1016/j.rmed.2007.01.019.
   PubMed Web of Science ®Google Scholar
• Boulet LP, FitzGerald JM, McIvor RA, Zimmerman S, Chapman KR. Influence of current or former smoking on asthma management and control. Can Respir J. 2008;15(5):275–9. doi:10.1155/2008/725074. PubMed PMID:18716691.
   PubMed Web of Science ®Google Scholar
• Boulet LP, Lemiere C, Archambault F, Carrier G, Descary MC, Deschesnes F. Smoking and asthma: clinical and radiologic features, lung function, and airway inflammation. Chest 2006;129(3):661–8. doi:10.1378/chest.129.3.661.
   PubMed Web of Science ®Google Scholar
• St-Laurent J, Bergeron C, Page N, Couture C, Laviolette M, Boulet LP. Influence of smoking on airway inflammation and remodelling in asthma. Clin Exp Allergy. 2008;38(10):1582–9. doi:10.1111/j.1365-2222.2008.03032.x.
   PubMed Web of Science ®Google Scholar
• Gibson PG, Simpson JL. The overlap syndrome of asthma and COPD: what are its features and how important is it? Thorax 2009;64(8):728–35. doi:10.1136/thx.2008.108027.
   PubMed Web of Science ®Google Scholar
• Barnes PJ. Immunology of asthma and chronic obstructive pulmonary disease. Nat Rev Immunol. 2008;8(3):183–92. doi:10.1038/nri2254.
   PubMed Web of Science ®Google Scholar
• Alshabanat A, Zafari Z, Albanyan O, Dairi M, FitzGerald JM. Asthma and COPD overlap syndrome (ACOS): a systematic review and meta analysis. PLoS One 2015;10(9):e0136065. doi:10.1371/journal.pone.0136065.
   PubMed Web of Science ®Google Scholar
• Cazzola M, Rogliani P. Do we really need asthma-chronic obstructive pulmonary disease overlap syndrome? J Allergy Clin Immunol. 2016;138(4):977–83. doi:10.1016/j.jaci.2016.04.028.
   PubMed Web of Science ®Google Scholar
• Zeki AA, Jarjour NN. The asthma-chronic obstructive pulmonary disease overlap syndrome: a new take on an old concept. Ann Am Thorac Soc. 2016;13(9):1440–2. doi:10.1513/AnnalsATS.201606-493ED.
   PubMed Web of Science ®Google Scholar
• Rodrigo GJ, Neffen H, Plaza V. Asthma-chronic obstructive pulmonary disease overlap syndrome: a controversial concept. Curr Opin Allergy Clin Immunol. 2017;17(1):36–41. doi:10.1097/ACI.0000000000000326.
   PubMed Web of Science ®Google Scholar
• Global initiative for asthma (GINA) and Global initiative of obstructive lung disease (GOLD). Diagnosis and initial treatment of asthme, COPD and asthma-COPD overlap. Ajoint project of GINA and GOLD updated April 2017 [accessed September 2017]. Available from: www.ginasthma.org.
   Google Scholar
• Juniper EF, Bousquet J, Abetz L, Bateman ED. Identifying ‘well-controlled’ and ‘not well-controlled’ asthma using the Asthma Control Questionnaire. Respir Med. 2006;100(4):616–21. doi:10.1016/j.rmed.2005.08.012.
   PubMed Web of Science ®Google Scholar
• Boulet LP, Boulet V, Milot J. How should we quantify asthma control? Chest 2002;122(6):2217–23. doi:10.1378/chest.122.6.2217.
   PubMed Web of Science ®Google Scholar
• LeBlanc A, Robichaud P, Lacasse Y, Boulet LP. Quantification of asthma control: validation of the Asthma Control Scoring System. Allergy 2007;62(2):120–5. doi:10.1111/j.1398-9995.2006.01194.x.
   PubMed Web of Science ®Google Scholar
• Juniper EF, Guyatt GH, Cox FM, Ferrie PJ, King DR. Development and validation of the Mini Asthma Quality of Life Questionnaire. Eur Respir J. 1999;14(1):32–8. doi:10.1034/j.1399-3003.1999.14a08.x.
   PubMed Web of Science ®Google Scholar
• Reddel HK, Taylor DR, Bateman ED, Boulet LP, Boushey HA, Busse WW, et al. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med. 2009;180(1):59–99. doi:10.1164/rccm.200801-060ST.
   PubMed Web of Science ®Google Scholar
• Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319–38. doi:10.1183/09031936.05.00034805.
   PubMed Web of Science ®Google Scholar
• Quanjer PH, Stanojevic S, Cole TJ, Baur X, Hall GL, Culver BH, et al. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J. 2012;40(6):1324–43. doi:10.1183/09031936.00080312.
   PubMed Web of Science ®Google Scholar
• Quanjer PH, Brazzale DJ, Boros PW, Pretto JJ. Implications of adopting the Global Lungs 2012 all-age reference equations for spirometry. Eur Respir J. 2013;42(4):1046–54. doi:10.1183/09031936.00195512.
   PubMed Web of Science ®Google Scholar
• Wanger J, Clausen JL, Coates A, Pedersen OF, Brusasco V, Burgos F, et al. Standardisation of the measurement of lung volumes. Eur Respir J. 2005;26(3):511–22. doi:10.1183/09031936.05.00035005.
   PubMed Web of Science ®Google Scholar
• Macintyre N, Crapo RO, Viegi G, Johnson DC, van der Grinten CP, Brusasco V, et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J. 2005;26(4):720–35. doi:10.1183/09031936.05.00034905.
   PubMed Web of Science ®Google Scholar
• ATS/ERS. Recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med. 2005;171(8):912–30. doi:10.1164/rccm.200406-710ST.
   PubMed Web of Science ®Google Scholar
• Pin I, Gibson PG, Kolendowicz R, Girgis-Gabardo A, Denburg JA, Hargreave FE, et al. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax. 1992;47(1):25–9. doi:10.1136/thx.47.1.25.
   PubMed Web of Science ®Google Scholar
• Pizzichini E, Pizzichini MM, Efthimiadis A, Evans S, Morris MM, Squillace D, et al. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med. 1996;154(2 Pt 1):308–17. doi:10.1164/ajrccm.154.2.8756799.
   PubMed Web of Science ®Google Scholar
• Colak Y, Afzal S, Nordestgaard BG, Lange P. Characteristics and prognosis of never-smokers and smokers with asthma in the Copenhagen general population study. A Prospective Cohort Study. Am J Respir Crit Care Med. 2015;192(2):172–81. doi:10.1164/rccm.201502-0302OC.
   PubMed Web of Science ®Google Scholar
• Laforest L, Van Ganse E, Devouassoux G, Bousquet J, Chretin S, Bauguil G, et al. Influence of patients' characteristics and disease management on asthma control. J Allergy Clin Immunol. 2006;117(6):1404–10. doi:10.1016/j.jaci.2006.03.007.
   PubMed Web of Science ®Google Scholar
• Uchmanowicz B, Panaszek B, Uchmanowicz I, Rosinczuk J. Clinical factors affecting quality of life of patients with asthma. Patient Prefer Adherence. 2016;10:579–89. doi:10.2147/PPA.S103043.
   PubMed Web of Science ®Google Scholar
• Lange P, Colak Y, Ingebrigtsen TS, Vestbo J, Marott JL. Long-term prognosis of asthma, chronic obstructive pulmonary disease, and asthma-chronic obstructive pulmonary disease overlap in the Copenhagen City Heart study: a prospective population-based analysis. Lancet Respir Med. 2016;4(6):454–62. doi:10.1016/S2213-2600(16)00098-9.
   PubMed Web of Science ®Google Scholar
• Damera G, Panettieri RA. Irreversible airway obstruction in asthma: what we lose, we lose early. Allergy Asthma Proc. 2014;35(2):111–8. doi:10.2500/aap.2013.34.3724.
   PubMed Web of Science ®Google Scholar
• Gelb AF, Christenson SA, Nadel JA. Understanding the pathophysiology of the asthma-chronic obstructive pulmonary disease overlap syndrome. Curr Opin Pulm Med. 2016;22(2):100–5. doi:10.1097/MCP.0000000000000236.
   PubMed Web of Science ®Google Scholar
• Ouellet K, Bacon SL, Boudreau M, Plourde A, Moullec G, Lavoie KL. Individual and combined impact of cigarette smoking, anxiety, and mood disorders on asthma control. Nicotine Tob Res. 2012;14(8):961–9. doi:10.1093/ntr/ntr315.
   PubMed Web of Science ®Google Scholar
• Kitaguchi Y, Yasuo M, Hanaoka M. Comparison of pulmonary function in patients with COPD, asthma-COPD overlap syndrome, and asthma with airflow limitation. Int J Chron Obstruct Pulmon Dis. 2016;11:991–7. doi:10.2147/COPD.S105988.
   PubMed Web of Science ®Google Scholar
• Shimoda T, Obase Y, Kishikawa R, Iwanaga T. Influence of cigarette smoking on airway inflammation and inhaled corticosteroid treatment in patients with asthma. Allergy Asthma Proc. 2016;37(4):50–8. doi:10.2500/aap.2016.37.3944.
   PubMed Web of Science ®Google Scholar
• Chalmers GW, Macleod KJ, Thomson L, Little SA, McSharry C, Thomson NC. Smoking and airway inflammation in patients with mild asthma. Chest 2001;120(6):1917–22. doi:10.1378/chest.120.6.1917.
   PubMed Web of Science ®Google Scholar
• Cosio BG, Perez de Llano L, Lopez Vina A, Torrego A, Lopez-Campos JL, Soriano JB, et al. Th-2 signature in chronic airway diseases: towards the extinction of asthma-COPD overlap syndrome? Eur Respir J. 2017;49(5). doi:10.1183/13993003.02397-2016.
   Web of Science ®Google Scholar
• Thomson NC, Chaudhuri R. Asthma in smokers: challenges and opportunities. Curr Opin Pulm Med. 2009;15(1):39–45. doi:10.1097/MCP.0b013e32831da894.
   PubMed Web of Science ®Google Scholar
• Tommola M, Ilmarinen P, Tuomisto LE, Lehtimaki L, Haanpaa J, Niemela O, et al. Differences between asthma-COPD overlap syndrome and adult-onset asthma. Eur Respir J. 2017;49(5):doi:10.1183/13993003.02383-2016.
   PubMed Web of Science ®Google Scholar
• Van Dijk WD, Gupta N, Tan WC, Bourbeau J. Clinical relevance of diagnosing COPD by fixed ratio or lower limit of normal: a systematic review. COPD 2014;11(1):113–20. doi:10.3109/15412555.2013.781996.
   PubMedGoogle Scholar
• Global Strategy for the Diagnosis, Management and Prevention of COPD. Global Initiative for Chronic Obstructive Lung Disease (GOLD). [Accessed August 2017]. Available from: http://www.goldcopd.org/.
   Google Scholar
• van Dijk W, Tan W, Li P, Guo B, Li S, Benedetti A, et al. Clinical relevance of fixed ratio vs. lower limit of normal of FEV1/FVC in COPD: patient-reported outcomes from the CanCOLD cohort. Ann Fam Med. 2015;13(1):41–8. doi:10.1370/afm.1714.
   PubMed Web of Science ®Google Scholar
• Sin DD, Miravitlles M, Mannino DM, Soriano JB, Price D, Celli BR, et al. What is asthma-COPD overlap syndrome? Towards a consensus definition from a round table discussion. Eur Respir J. 2016;48(3):664–73.doi:10.1183/13993003.00436-2016.
   PubMed Web of Science ®Google Scholar
• Caillaud D, Chanez P, Escamilla R, Burgel PR, Court-Fortune I, Nesme-Meyer P, et al. Asthma-COPD overlap syndrome (ACOS) vs ‘pure’ COPD: a distinct phenotype? Allergy. 2017;72(1):137–45. doi:10.1111/all.13004.
   PubMed Web of Science ®Google Scholar